Trinity Life Sciences is a strategic, tech-enabled commercialization company that supports pharmaceutical, biotech, and medtech firms in developing, launching, and optimizing new medical innovations. Founded in 1996, the company operates across North America, Europe, Latin America, and Asia Pacific, serving over 350 industry-leading customers globally.
The firm's work spans artificial intelligence, analytics, real-world evidence, and technology platforms. It has been involved in approximately 70% of all new drug launches and claims its models can predict up to 90% of revenue outcomes. Its proprietary technology platforms include TrinityEDGE™ and InsightsEDGE™, both designed for life sciences commercialization.
Trinity Life Sciences works with clients across the pharmaceutical, biotechnology, and medical technology sectors. The company's focus on data-driven commercialization strategies positions it as a key partner for organizations navigating the complexities of bringing new therapies and devices to market.
